Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04863664 · ClinicalTrials.gov registry record · NA
Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
A NA study of Tachyarrhythmia, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 998
- Enrollment target
- 20
- Study locations
NCT04863664: Completed NA study of Tachyarrhythmia, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT04863664 is a NA study of Tachyarrhythmia that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 998 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04863664, a NA study of Tachyarrhythmia, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 998 participants
- Enrollment target
- 20
- Study locations
Study Summary
The LEADR study is designed to assess the safety and efficacy of the Next Generation ICD lead. The LEADR LBBAP study is being conducted under the existing US FDA Investigational Device Exemption (IDE) for the Next Generation ICD Lead and is designed to confirm the safety and defibrillation efficacy of the Next Generation ICD Lead when placed in the LBBAP location in ICD and LOT-CRT patient population.
Primary Outcome
Subjects free of Next Generation ICD lead-related complication at 6 months post-implant.
Conditions Studied
Interventions
- DEVICE Defibrillation (RV Implant)
- DEVICE Defibrillation (LBBAP Implant)
Study Locations (20)
Ohio
- LEADR: TriHealth Hatton Research Institute - Cincinnati
- LEADR LBBAP: The Christ Hospital - Cincinnati
- LEADR: Cleveland Clinic - Cleveland
- LEADR LBBAP: The Ohio State University Wexner Medical Center - Columbus
Pennsylvania
- LEADR: Lehigh Valley Hospital - Cedar Crest - Allentown
- LEADR: Hospital of the University of Pennsylvania - Philadelphia
- LEADR LBBAP: Geisinger Wyoming Valley Medical Center - Wilkes-Barre
Missouri
- LEADR: Saint Luke's Mid America Heart Institute - Kansas City
- LEADR: Washington University School of Medicine - St Louis
Texas
- LEADR: Texas Cardiac Arrhythmia Research Foundation - Austin
- LEADR: Texas Health Fort Worth Hospital - Fort Worth
Alabama
- LEADR: Heart Center Research - Huntsville
California
- LEADR LBBAP: Torrance Memorial Medical Center - Torrance
Connecticut
- LEADR: Hartford Hospital - Hartford
Florida
- LEADR: University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 998 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2025-11-06 |
| Phase | NA |
What the finished NCT04863664 record still lists
NCT04863664 is an interventional study that assigns participants to a tested intervention. The registered 998 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Tachyarrhythmia appearing as the primary indexed condition, and to 2 interventions - of which Defibrillation (RV Implant) is the first listed.
NCT04863664 names 20 study sites across 13 states, led by Ohio, Pennsylvania, Missouri.
Frequently Asked Questions
What is clinical trial NCT04863664 about?
NCT04863664 is a clinical study titled "Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)". The LEADR study is designed to assess the safety and efficacy of the Next Generation ICD lead. The LEADR LBBAP study is being conducted under the existing US FDA Investigational Device Exemption (IDE) for the Next Generation ICD Lead and is designed to confirm the safety and defibrillation efficacy...
What is the current status of trial NCT04863664?
This trial is currently completed. It is a NA study. The enrollment target is 998 participants. The study started on 2021-06-21. Estimated completion is 2025-11-06.
What conditions does trial NCT04863664 study?
This clinical trial studies the following conditions: Tachyarrhythmia.
What interventions are being tested in trial NCT04863664?
The interventions under investigation include: Defibrillation (RV Implant) (DEVICE), Defibrillation (LBBAP Implant) (DEVICE).
Who is sponsoring clinical trial NCT04863664?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04863664 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachyarrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04863664's enrollment target sits among peer trials
998 121st of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02986048 · 999 participants
Proton Therapy Patient Registry
- NCT04703244 · 999 participants
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI